Trials / Completed
CompletedNCT00000274
Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics - 9
Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (planned)
- Sponsor
- National Institute on Drug Abuse (NIDA) · NIH
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and efficacy of flupenthixol and haloperidol for cocaine dependence in individuals with schizophrenia/schizoaffective illness.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Flupenthixol |
Timeline
- Start date
- 1997-03-01
- Completion
- 1999-05-01
- First posted
- 1999-09-21
- Last updated
- 2017-01-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00000274. Inclusion in this directory is not an endorsement.